Pressure BioSciences announces stock repurchase program

By Elaine Rigoli

Tampa, Fla., Sept. 25 - Pressure BioSciences, Inc. announced that its board of directors has authorized the company to repurchase up to $500,000 of its outstanding common stock on the open market or in privately negotiated transactions.

The timing and amount of share repurchases, if any, will depend on a number of factors, including market and business conditions.

The repurchases may start or stop at any time without prior notice and without further announcement.

The company also announced that pursuant to this authorization it purchased 106,600 shares of its common stock at $2.88 per share from Kyowa Medex Co. Ltd., the Japanese distributor of the company's legacy business Boston Biomedica, Inc.

Based in West Bridgewater, Mass., Pressure BioSciences is an early stage company focused on the development of a novel, enabling technology called pressure cycling technology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.